|
DDX20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.5043083686287E-14 |
| Normal-vs-Stage2 |
2.00910000003329E-06 |
| Normal-vs-Stage3 |
3.12572190352967E-12 |
| Normal-vs-Stage4 |
2.81830114801096E-12 |
| Stage1-vs-Stage2 |
4.377400E-01 |
| Stage1-vs-Stage3 |
1.194760E-01 |
| Stage1-vs-Stage4 |
9.900000E-03 |
| Stage2-vs-Stage3 |
1.007160E-01 |
| Stage2-vs-Stage4 |
9.715500E-03 |
| Stage3-vs-Stage4 |
2.404000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66533453693773E-15 |
| Normal-vs-AfricanAmerican |
1.92816999999845E-05 |
| Normal-vs-Asian |
1.38179999997767E-06 |
| Caucasian-vs-AfricanAmerican |
9.044800E-01 |
| Caucasian-vs-Asian |
2.093000E-01 |
| AfricanAmerican-vs-Asian |
4.947800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.81086265374597E-12 |
| Normal-vs-Female |
1.62936331093988E-12 |
| Male-vs-Female |
9.798000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12851958281135E-12 |
| Normal-vs-Age(41-60Yrs) |
3.9146463848283E-13 |
| Normal-vs-Age(61-80Yrs) |
8.33899616026201E-11 |
| Normal-vs-Age(81-100Yrs) |
1.541340E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.749200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.016400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.355000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.261600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.897200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.630800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.215700E-03 |
| Classical-VS-Follicular |
2.641400E-01 |
| Classical-VS-Other |
3.828400E-01 |
| Classical-VS-Normal |
2.70428124338196E-12 |
| Tall-VS-Follicular |
7.469700E-02 |
| Tall-VS-Other |
5.997200E-01 |
| Tall-VS-Normal |
2.84929857485849E-11 |
| Follicular-VS-Other |
6.369000E-01 |
| Follicular-VS-Normal |
2.5464996777913E-10 |
| Other-VS-Normal |
1.902370E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.71782637798424E-12 |
| Normal-vs-N1 |
1.38290046081124E-10 |
| N0-vs-N1 |
1.094000E-01 |
|
|
